Skip to main content

Featured post

Marketers Will Pay Naira for Dangote Fuel -IPMAN

Aliko Dangote Refined petroleum products from the $20bn Dangote Petroleum Refinery are to be sold in naira and not in the United States dollar as speculated in some quarters, oil marketers clarified on Monday. Dealers in the downstream oil sector also stated that the registration process for marketers at the refinery was still ongoing, as many operators had continued to register with the plant. It was further gathered that officials of the Nigerian Midstream and Downstream Petroleum Regulatory Authority were meeting with the management of the refinery to perfect the pricing template for products produced by the facility. On January 12, 2023, the Dangote Petroleum Refinery announced the commencement of production of Automotive Gas Oil, also known as diesel, and JetA1 or aviation fuel. The President, Dangote Group, Aliko Dangote, had in a statement issued by the firm, said, “We have started the production of diesel and aviation fuel, and the products will be in the market within this mon...

Could New COVID Variants Undermine Vaccines? Labs Scramble to Find Out


Researchers race to determine why variants identified in Britain and South Africa spread so quickly and whether they’ll compromise vaccines

Could New COVID Variants Undermine Vaccines? Labs Scramble to Find Out
Paramedics assess a Covid-19 patient in Lenasia, Johannesburg, on January 4, 2021. Currently suffering a second wave of infections, of which the majority are a new variant of the coronavirus, South Africa is the hardest hit country on the African continent. Credit: Michele Spatari Getty Images

As concern grows over faster-spreading variants of coronavirus, labs worldwide are racing to unpick the biology of these viruses. Scientists want to understand why SARS-CoV-2 variants identified in the United Kingdom and South Africa seem to be spreading so quickly, and whether they might diminish the potency of vaccines or overcome natural immunity and lead to spate of reinfections.

“Many of us are scrambling to make sense of the new variants, and the million-dollar question is what significance this will have for the effectiveness of vaccines that are currently being administered,” says Jeremy Luban, a virologist at the University of Massachusetts Medical School in Worcester.

Source

Comments